Evidence map›Paper›PMID 31733690›Full record

ReviewClinics in geriatric medicine2020

Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology.

David K Simon, Caroline M Tanner, Patrik Brundin

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Clinics in geriatric medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 537 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
537citing papers in PubMed, 12 pooled it
42.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06536348 recruitingnot on this mapstarted 2025, after this paper: background citation

PARKINSON BRASIL - Database on Motor and Non-Motor Aspects of Parkinson's Disease in Brazil

TypeobservationalSponsorFederal University of UberlandiaRan2025 to 2034Enrolled958ConditionsParkinson Disease
NCT06838741 naenrolling by invitationnot on this mapstarted 2024, after this paper: background citation

Comparison of Effects of Virtual Reality and Otago Exercises on Balance, Gait and Activities of Daily Living in Parkinson's Disease Patients.

TypeinterventionalSponsorRiphah International UniversityRan2024 to 2025Enrolled74ConditionsParkinson DiseaseArmsotago exercises, virtual reality
NCT07068217 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Metronome-Based Structured Rhythmic Exercise Program on Freezing and Gait Parameters in Parkinson Disease

TypeinterventionalSponsorMedipol UniversityRan2025 to 2026Enrolled26ConditionsPARKINSON DISEASE (Disorder)ArmsExercise
3 · Its place in the literature

Who cites it

537 citing papers in PubMed, 12 syntheses or guidelines pooled it, 1,031 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. The Role of miRNAs in Parkinson's Disease: A Systematic Review.International journal of molecular sciences · 2025
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Article
  15. Article
  16. A novel oxidative-inflammatory biomarker for Parkinson's disease: clinical utility of the uric acid-to-albumin ratio.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

477 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

David K SimonBeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue Boston, MA 02215, USA. Electronic address: dsimon1@bidmc.harvard.edu.
Caroline M TannerDepartment of Neurology, University of California - San Francisco, 1635 Divisadero St., Suite 520-530, San Francisco, CA 94115; Parkinson's Disease Research Education and Clinical Center San Francisco Veteran's Affairs Medical Center, 4150 Clement St. (127P), San Francisco, CA 94121.
Patrik BrundinCenter for Neurodegenerative Science, Van Andel Institute, 333 Bostwick Avenue Northeast, Grand Rapids, MI 49503-2518, USA.
Harvard University · USUniversity of California, San Francisco · USVan Andel Institute · US

Funding

Prevention of Fractures in Patients with Parkinson's DiseaseR01AG059417 · NIA · CALIFORNIA PACIFIC MED CTR RES INSTITUTE · PI CUMMINGS, STEVEN RON, TANNER, CAROLINE M. · 2018 to 2024
$32.6M
Linking Synucleinopathy and Dysfunction of Olfactory PathwaysR01DC016519 · NIDCD · VAN ANDEL RESEARCH INSTITUTE · PI MOORE, DARREN JOHN, WESSON, DANIEL W · 2017 to 2021
$2.8M
PGC-1alpha and Pitx3 as individual and combined targets for neuroprotectionR01NS086352 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SIMON, DAVID K. · 2014 to 2018
$1.9M
Mitochondrial mechanisms and vulnerability to alpha-synuclein toxicityR21NS094840 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SIMON, DAVID K. · 2017 to 2018
$476k
NIA NIH HHS R01 AG059417NIDCD NIH HHS R01 DC016519NINDS NIH HHS R01 NS086352NINDS NIH HHS R21 NS094840
6 · The paper itself

Abstract

Parkinson disease is a complex, age-related, neurodegenerative disease associated with dopamine deficiency and both motor and nonmotor deficits. Many environmental and genetic factors influence Parkinson disease risk, with different factors predominating in different patients. These factors converge on specific pathways, including mitochondrial dysfunction, oxidative stress, protein aggregation, impaired autophagy, and neuroinflammation. Ultimately, treatment of Parkinson disease may focus on targeted therapies for pathophysiologically defined subtypes of Parkinson disease patients.

Indexed as

Parkinson DiseaseAgedGenetic Predisposition to DiseaseHealth Status IndicatorsHumansMetabolismNeuroimmunomodulationPatient Care ManagementEpidemiologyGeneticsMitochondrialNeuroprotectionParkinson diseasePathologyPathophysiologySynuclein

Identifiers

PMID31733690
PMCPMC6905381
OpenAlexW2969956278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.